跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
注射用亚锡替曲膦 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Tetrofosmin and Stannous Chloride for Injection
Approved
化学药品
Tetrofosmin and Stannous Chloride for Injection
GE Healthcare AS
🇨🇳 National Medical Products Administration
Approval Date
Mar 29, 2022
Approval ID
8FFrC9oe0Aa
Company
GE Healthcare AS
Type
化学药品
Approval Details
Approval Id
8FFrC9oe0Aa
Approval Number
国药准字HJ20220026
Generic Name
注射用亚锡替曲膦
Generic Name En
Tetrofosmin and Stannous Chloride for Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
每瓶内含替曲膦0.23mg与亚锡15.8μg
Reg Date
2022-03-29
Expired Date
2027-03-28
Company Name
GE Healthcare AS
Production Company Name
GE Healthcare AS
Company Detail Path
/organization/ge-healthcare-as
Production Company Detail Path
/organization/ge-healthcare-as
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 29, 2022
Approval ID
8FFrC9oe0Aa
Type
化学药品
Back to NMPA Approvals
